98 related articles for article (PubMed ID: 15129986)
21. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
Sankalia JM; Sankalia MG; Mashru RC
J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
[TBL] [Abstract][Full Text] [Related]
22. Novel interpenetrating network microspheres of xanthan gum-poly(vinyl alcohol) for the delivery of diclofenac sodium to the intestine--in vitro and in vivo evaluation.
Ray S; Banerjee S; Maiti S; Laha B; Barik S; Sa B; Bhattacharyya UK
Drug Deliv; 2010; 17(7):508-19. PubMed ID: 20482471
[TBL] [Abstract][Full Text] [Related]
23. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
Kołodziejczyk MK; Kołodziejska J; Zgoda MM
Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
[TBL] [Abstract][Full Text] [Related]
24. Development of gastro intestinal sustained release tablet formulation containing acryl-EZE and pH-dependent swelling HPMC K 15 M.
Lamoudi L; Chaumeil JC; Daoud K
Drug Dev Ind Pharm; 2012 May; 38(5):515-20. PubMed ID: 21978389
[TBL] [Abstract][Full Text] [Related]
25. Xanthan gum to tailor drug release of sustained-release ethylcellulose mini-matrices prepared via hot-melt extrusion: in vitro and in vivo evaluation.
Verhoeven E; Vervaet C; Remon JP
Eur J Pharm Biopharm; 2006 Jul; 63(3):320-30. PubMed ID: 16517135
[TBL] [Abstract][Full Text] [Related]
26. Formulation variables influencing drug release from layered matrix system comprising chitosan and xanthan gum.
Phaechamud T; Ritthidej GC
AAPS PharmSciTech; 2008; 9(3):870-7. PubMed ID: 18654863
[TBL] [Abstract][Full Text] [Related]
27. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
Savaşer A; Ozkan Y; Işimer A
Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
[TBL] [Abstract][Full Text] [Related]
28. Hydroxyethyl Pachyman as a novel excipient for sustained-release matrix tablets.
Zhou X; Wang P; Wang J; Liu Z; Hong X; Xiao Y; Liu P; Hu X
Carbohydr Polym; 2016 Dec; 154():1-7. PubMed ID: 27577889
[TBL] [Abstract][Full Text] [Related]
29. In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices.
Bravo SA; Lamas MC; Salamón CJ
J Pharm Pharm Sci; 2002; 5(3):213-9. PubMed ID: 12553888
[TBL] [Abstract][Full Text] [Related]
30. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
Efentakis M; Naseef H; Vlachou M
Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
[TBL] [Abstract][Full Text] [Related]
31. Properties of sustained release hot-melt extruded tablets containing chitosan and xanthan gum.
Fukuda M; Peppas NA; McGinity JW
Int J Pharm; 2006 Mar; 310(1-2):90-100. PubMed ID: 16413153
[TBL] [Abstract][Full Text] [Related]
32. Konjac glucomannan/xanthan gum enzyme sensitive binary mixtures for colonic drug delivery.
Alvarez-Manceñido F; Landin M; Martínez-Pacheco R
Eur J Pharm Biopharm; 2008 Jun; 69(2):573-81. PubMed ID: 18294827
[TBL] [Abstract][Full Text] [Related]
33. Elucidation of the Controlled-Release Behavior of Metoprolol Succinate from Directly Compressed Xanthan Gum/Chitosan Polymers: Computational and Experimental Studies.
Dadou SM; El-Barghouthi MI; Antonijevic MD; Chowdhry BZ; Badwan AA
ACS Biomater Sci Eng; 2020 Jan; 6(1):21-37. PubMed ID: 33463201
[TBL] [Abstract][Full Text] [Related]
34. Xanthan-galactomannan interactions as related to xanthan conformations.
Bresolin TM; Milas M; Rinaudo M; Ganter JL
Int J Biol Macromol; 1998 Nov; 23(4):263-75. PubMed ID: 9849624
[TBL] [Abstract][Full Text] [Related]
35. Modulation of microenvironmental pH for dual release and reduced in vivo gastrointestinal bleeding of aceclofenac using hydroxypropyl methylcellulose-based bilayered matrix tablet.
Kang WH; Nguyen HV; Park C; Choi YW; Lee BJ
Eur J Pharm Sci; 2017 May; 102():85-93. PubMed ID: 28263912
[TBL] [Abstract][Full Text] [Related]
36. Incorporation of calcium salts into xanthan gum matrices: hydration, erosion and drug release characteristics.
Groves E; Chaw CS
Drug Dev Ind Pharm; 2015; 41(10):1608-16. PubMed ID: 25371230
[TBL] [Abstract][Full Text] [Related]
37. Optimization of pH-independent chronotherapeutic release of verapamil HCl from three-layer matrix tablets.
Al-Zoubi N; Alkhatib HS; Alobaidi G; Abdel-Rahim S; Obeidat W; Malamataris S
Int J Pharm; 2015 Oct; 494(1):296-303. PubMed ID: 26276259
[TBL] [Abstract][Full Text] [Related]
38. Design and characterization of neurodurable gellan-xanthan pH-responsive hydrogels for controlled drug delivery.
Ramburrun P; Kumar P; Choonara YE; du Toit LC; Pillay V
Expert Opin Drug Deliv; 2017 Mar; 14(3):291-306. PubMed ID: 27892726
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo application of pH-sensitive colon-targeting polysaccharide hydrogel used for ulcerative colitis therapy.
You YC; Dong LY; Dong K; Xu W; Yan Y; Zhang L; Wang K; Xing FJ
Carbohydr Polym; 2015 Oct; 130():243-53. PubMed ID: 26076623
[TBL] [Abstract][Full Text] [Related]
40. Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets.
Dvorácková K; Rabisková M; Masteiková R; Muselík J; Krejcová K
Drug Dev Ind Pharm; 2009 Aug; 35(8):930-40. PubMed ID: 19274510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
